登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ●中通国脉通信股份有限公司（以下简称"公司"）2022年度内部控制审计报告被致同会计师事务所（特 殊普通合伙）出具了否定意见，根据《上海证券交易所股票上市规则（2025年4月修订）》9.8.1条第 （三）项的规定，公司股票于2023年5月4日被上海证券交易所实施其他风险警示。 ●根据《上海证券交易所股票上市规则（2025年4月修订）》第9.8.5条："上市公司股票因9.8.1条第 （二）项至第（五）项规定情形被实施其他风险警示的，在被实施其他风险警示期间，公司应当至少每 月发布1次提示性公告，分阶段披露涉及事项的解决进展情况"。公司将每月披露一次其他风险警示相关 事项的进展情况，提示相关风险。 一、公司被实施其他风险警示的相关情况 2025年7月30日 二、公司被实施其他风险警示后所采取的措施 针对内部控制报告中涉及的相关问题，公司高度重视，经董事会研究决定，公司成立了内部控制整改小 组（以下简称"整改小组"），根 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券代码：603559 证券简称：ST 通脉 公告编号：2025-062 中通国脉通信股份有限公司 关于公司股票继续被实施其他风险警示相关事项的进展公告 ●中通国脉通信股份有限公司（以下简称"公司"）2022 年度内部控制审 计报告被致同会计师事务所（特殊普通合伙）出具了否定意见，根据《上海证券 交易所股票上市规则（2025 年 4 月修订）》9.8.1 条第（三）项的规定，公司股 票于 2023 年 5 月 4 日被上海证券交易所实施其他风险警示。 公司在 2024 年期间进行了重整，于 2024 年 12 月 30 日，被长春市中级人民 法院裁定确认公司《重整计划》执行完毕，并终结公司重整程序，公司按照相关 规定未披露 2024 年度财务报告内部控制审计报告。根据《上海证券交易所股票 上市规则（2025 年 4 月修订）》9.8.1 条第（三）项"最近一个会计年度财务报 告内部控制被出具无法表示意见或否定意见的审计报告，或未按照规定披露财务 ●根据《上海证券交 ...

New Stock Listings - Tech Source Group issued shares at a price of 10.88 CNY[1] - Shanda Power issued shares at a price of 14.66 CNY[1] Market Alerts - ST Zitian reported an equity date on July 21, 2025, with a link to the announcement[1] - Guangshengtang experienced severe abnormal fluctuations, with an announcement on July 17, 2025[1] - Huayin Power had an announcement on July 15, 2025, regarding market conditions[1] - Multiple companies including Shangwei New Materials, China Power Construction, and Jiangnan Chemical had announcements on July 23, 2025, regarding market activities[1] Abnormal Fluctuations - Companies such as ST Weier and ST Huadong reported significant fluctuations with announcements on July 21, 2025[2] - ST Jinyi and ST Yundong also reported abnormal fluctuations with announcements on July 17, 2025[2]

证券代码：603559 证券简称：ST 通脉 公告编号：2025-061 中通国脉通信股份有限公司 2025 年半年度业绩预告公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 1、本期业绩预告适用于净利润为亏损的情形。 2、中通国脉通信股份有限公司（以下简称"公司"）预计 2025 年半年度实 现归属于母公司所有者的净利润为-3,500.00 万元到-5,000.00 万元，将出现亏 损。 3、公司预计 2025 年半年度实现归属于母公司所有者的扣除非经常性损益后 的净利润为-3,000.00 万元到-4,500.00 万元。 （二）业绩预告情况 经财务部门初步测算，公司预计 2025 年半年度实现归属于母公司所有者的 净利润为-3,500.00 万元到-5,000.00 万元，将出现亏损。 公司预计 2025 年半年度实现归属于母公司所有者的扣除非经常性损益后的 净利润为-3,000.00 万元到-4,500.00 万元。 （三）本次业绩预告未经注册会计师审计。 二、上年同期经营业绩和财务状况 （一）20 ...

Group 1 - Shengde Xintai won a bid for a thermal power steel pipe project worth approximately 217 million yuan, accounting for 8.15% of its audited revenue for 2024 [1] - High-speed Electric's subsidiary won a project for the Shanghai-Nanjing-Hefei high-speed railway, with a bid amount of 71.76 million yuan [1] - Cangge Mining's subsidiary received a construction permit for a lithium-boron mining project, with a construction area of 106,900 square meters [2] Group 2 - China Electric Power Construction signed a mining transportation project contract in Guinea worth approximately 5.063 billion yuan, with a total duration of about 72 months [3] - Guobang Pharmaceutical's subsidiary completed the registration of an equity investment fund focusing on strategic emerging industries [4] - Deshi Co. obtained two invention patents related to oil and gas field development [5][26] Group 3 - Xue Tian Salt Industry expects a significant decrease in net profit for the first half of 2025, projecting a decline of 76.34% to 80.29% [6] - Rundu Co. received a drug registration certificate for moxifloxacin hydrochloride tablets, used for treating various bacterial infections [7] - China Nuclear Power reported a 15.65% increase in power generation in the first half of the year, with nuclear power generation up by 12.01% [8] Group 4 - Suqian Liansheng obtained two invention patents related to wastewater treatment methods [9] - Boshi Co. signed a 109 million yuan operation and maintenance service contract for solid product packaging [11] - *ST Sailong's subsidiary received a drug registration certificate for torasemide injection, used for various medical conditions [13] Group 5 - North Bay Port reported a 10.95% increase in cargo throughput for the first half of 2025, with container throughput also showing growth [14] - Kaiwei Te expects a revenue increase of 56.17% to 90.87% for the first half of 2025 [15] - Wankai New Materials plans to reduce production and conduct maintenance on 60,000 tons of PET capacity, affecting overall performance [16] Group 6 - Haiwang Bio's HW130 injection successfully completed Phase I clinical trials, showing good safety and tolerability [19] - Zhenai Meijia received a total of 22.8 million yuan in compensation for land acquisition, which will significantly impact its 2025 performance [20] - Changyuan Electric reported a 23.58% decrease in power generation in June, with a notable decline in thermal power generation [21] Group 7 - Shouxiangu's subsidiary completed the registration of two health food products [22] - Kailun Co. announced the resignation of its deputy general manager and board secretary [23] - Xibu Muye reported a 2.15% year-on-year increase in fresh milk production in June [24] Group 8 - Deshi Co. obtained two invention patents related to oil and gas field development [26] - Jingwei Huikai plans to acquire a 12.44% stake in Nuo Si Micro for 149 million yuan [27] - Electric Alloy completed the registration of its subsidiary in Mexico [29] Group 9 - Meinuohua expects a net profit increase of 142.84% to 174.52% for the first half of 2025 [30] - Guizhou Moutai repurchased approximately 3.38 million shares, accounting for 0.2692% of its total share capital [31][32] - Warner Pharmaceutical received approval for the listing application of a raw material drug for treating respiratory diseases [34] Group 10 - Yuan Dong Bio's independent director is under investigation for serious violations [35] - Dash Intelligent signed a contract for a smart project worth 11.88 million yuan [36] - Dayou Energy plans to transfer 586,500 tons of coal production capacity replacement indicators [37] Group 11 - Foton Motor reported a 150.96% increase in new energy vehicle sales in the first half of 2025 [39] - Renfu Pharmaceutical's shareholder plans to increase its stake by 1% to 2% [40] - Zongshen Power expects a net profit increase of 70% to 100% for the first half of 2025 [42] Group 12 - Yingboer plans to sell its wholly-owned subsidiary for 239 million yuan [44] - Changan Automobile reported a 1.59% increase in total vehicle sales in the first half of 2025 [46] - Fulian Precision signed a cooperation framework agreement with Sichuan Development Longmang [48] Group 13 - Nengte Technology plans to repurchase shares worth 300 million to 500 million yuan [50] - Longsoft Technology's controlling shareholder donated 3.43% of the company's shares [51] - Data Port's shareholders plan to reduce their holdings by up to 2% [52]

Key Points - Jiangnan Water received a stake increase from Lianan Life Insurance, reaching 5.03% of total shares [3] - Yingboer plans to transfer 100% equity of Zhuhai Dingyuan for 239 million yuan to optimize asset structure [4] - Chengbang Co. warns that its stock price fluctuations are not aligned with its fundamentals, as it has seen five consecutive trading days of price increases [6] - Weimais intends to invest 190 million yuan into its subsidiary for a new electric drive assembly project [7] - Fosun Pharma's subsidiary received EU GMP certification for its production facilities, indicating compliance with EU standards [8] - Jingwei Huikai plans to acquire an additional 12.44% stake in Nosi Micro, increasing its control in the semiconductor sector [9] - ST Tongmai will remove its delisting risk warning starting July 4, while continuing other risk warnings [10] - ST Modern seeks to apply for the removal of other risk warnings but will maintain delisting risk warnings [11] - Luxshare Precision is planning to issue H-shares for listing on the Hong Kong Stock Exchange [12] - Hainan Highway intends to purchase a 51% stake in Hainan Jiaokong Petrochemical, which will become a subsidiary [13] - Jucheng Co. plans to transfer 1.25% of its shares through a price inquiry [14] Performance Highlights - Foton Motor reported a 150.96% year-on-year increase in new energy vehicle sales for the first half of the year [15] - Jiangling Motors achieved a total vehicle sales of 172,700 units in the first half, up 8.15% year-on-year [16] - Changan Automobile's sales reached 1.3553 million units in the first half, with new energy vehicle sales growing by 49.05% [17] - Meinuohua expects a net profit increase of 142.84% to 174.52% for the first half of the year [18] - Jihong Co. anticipates a net profit increase of 55% to 65% for the first half of the year [19] - Nanjing Business Travel expects a net profit decrease of 67.4% to 78.27% for the first half of the year [20] - Madi Technology forecasts a net profit of 25 million to 27 million yuan, marking a turnaround from losses in the previous year [21] Major Contracts - Dash Intelligent signed a contract for an intelligent project worth 11.88 million yuan [22] - Jinyi Industrial won a bid for a 335 million yuan intercity railway materials procurement project [23] - Sichuan Road and Bridge signed a construction contract worth approximately 11.596 billion yuan [24] - Fulian Precision signed a cooperation framework agreement with Chuanfa Longmang for lithium battery material projects [26] Share Buybacks - Kweichow Moutai repurchased 72,000 shares in June, totaling 1.02 billion yuan [27] - Feiwo Technology plans to repurchase shares worth 25 million to 50 million yuan [28] - Nengte Technology intends to repurchase shares worth 300 million to 500 million yuan for capital reduction [29] - CATL has repurchased 6.641 million A-shares for a total of 1.551 billion yuan [30] Shareholding Changes - Renfu Pharmaceutical's shareholder plans to increase its stake by 1% to 2% [31] - Sanwei Xinan's shareholder intends to reduce its stake by up to 2% [33] - Data Port's shareholders plan to reduce their stakes by up to 2% [34] - Zhuzhou Design's controlling shareholders plan to reduce their stakes by up to 3% [35] - Tianji Co.'s controlling shareholders plan to reduce their stakes by up to 3% [36] - Anjisi's shareholders plan to reduce their stakes by up to 4% [37] Financing Activities - CITIC Securities received approval to issue up to 20 billion yuan in perpetual subordinated bonds [39]

证券代码：603559 证券简称：*ST 通脉 公告编号：2025-060 中通国脉通信股份有限公司 关于撤销退市风险警示、撤销部分其他风险警示 及继续实施其他风险警示暨停牌的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券停复牌情况：适用 中兴华会计师事务所（特殊普通合伙）（以下简称"中兴华"）对中通国脉通 信股份有限公司（以下简称"公司"）出具了标准无保留意见的《中通国脉通信股 份有限公司 2024 年度合并及母公司财务报表审计报告书》及《关于中通国脉通信 股份有限公司 2023 年度审计报告无法表示意见所涉及事项的重大影响消除情况的 审核报告》等报告，公司触及的退市风险警示及部分其他风险警示情形已消除， 公司已于 2025 年 4 月 28 日按照《上海证券交易所股票上市规则》（以下简称"《股 票上市规则》"）的相关规定向上海证券交易所（以下简称"上交所"）申请撤销相 应的退市风险警示及部分其他风险警示。上交所于 2025 年 7 月 2 日同意撤销对公 司股票实施的退市风险警示及部分其他风险警 ...

*ST通脉（603559）公告，中兴华会计师事务所对公司出具了标准无保留意见的《中通国脉通信股份有 限公司2024年度合并及母公司财务报表审计报告书》及《关于中通国脉通信股份有限公司2023年度审计 报告无法表示意见所涉及事项的重大影响消除情况的审核报告》等报告，公司触及的退市风险警示及部 分其他风险警示情形已消除。公司已于2025年4月28日向上交所申请撤销相应的退市风险警示及部分其 他风险警示。上交所于2025年7月2日同意撤销对公司股票实施的退市风险警示及部分其他风险警示，并 继续实施其他风险警示。公司股票将于2025年7月3日停牌1天，并于2025年7月4日开市起复牌。公司股 票仍在风险警示板交易，股票价格的日涨跌幅限制仍为5%。 ...

证券代码：603559 证券简称：*ST 通脉 公告编号：2025-059 中通国脉通信股份有限公司 关于公司股票继续被实施其他风险警示相关事项的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●中通国脉通信股份有限公司（以下简称"公司"）因 2023 年度被会计师 事务所出具了无法表示意见的审计报告，报告显示当时公司持续经营能力存在不 确定性，当时主要银行账户被冻结，触及《上海证券交易所股票上市规则》（以 下简称"《股票上市规则》"）的相关规定，公司股票被实施退市风险警示。 ●公司因被会计师事务所出具了否定意见的《2022 年度内部控制审计报告》 及《2023 年度内部控制审计报告》，根据《股票上市规则》的相关规定，公司 股票被继续实施其他风险警示。 1 的致同审字（2024）第 320A017425 号内控审计报告）。根据《股票上市规则》 的相关规定，股票被实施其他风险警示。具体内容详见公司于 2023 年 4 月 28 日披露的《中通国脉通信股份有限公司股票交易实施其他风险警示暨公司股票停 牌的 ...

Core Viewpoint - Zhongtong Guomai Communication Co., Ltd. has applied to the Shanghai Stock Exchange to revoke the delisting risk warning and other risk warnings, as the conditions triggering these warnings have been eliminated [1][2]. Financial Reporting and Audit - The company received an audit report for the 2023 annual report that was unable to express an opinion due to limitations in the confirmation procedures for accounts receivable, inventory, and revenue [1][2]. - The 2024 annual report is expected to receive a standard unqualified audit opinion, as the issues affecting the 2023 report have been resolved [1][2]. - The company has established a special collection team to expedite the recovery of accounts receivable and has achieved a response rate of 80%-90% for major items [1][2]. Audit Procedures - The audit procedures for accounts receivable included verifying the validity and accuracy of contracts, invoices, and related documents, as well as assessing the adequacy of bad debt provisions [2][3]. - For inventory, the audit involved physical verification and assessment of net realizable value to ensure proper impairment provisions [2][3]. - Revenue recognition was audited by verifying contracts, invoices, and related documents, and ensuring compliance with accounting standards [3][4]. Specific Audit Findings - For the 2023 fiscal year, the reported amounts for accounts receivable, revenue, and inventory were as follows: - Accounts Receivable: CNY 602.82 million, with a confirmation response rate of 77.71% [4]. - Revenue: CNY 306.18 million, with a confirmation response rate of 82.43% [4]. - Inventory: CNY 378.90 million, with a confirmation response rate of 70.72% [4]. - The 2024 fiscal year showed an increase in reported amounts: - Accounts Receivable: CNY 793.81 million, with a confirmation response rate of 80.04% [6]. - Revenue: CNY 355.43 million, with a confirmation response rate of 81.65% [6]. - Inventory: CNY 242.22 million, with a confirmation response rate of 74.27% [6]. Adjustments and Corrections - The company has made retrospective adjustments to financial statements for the years 2015-2023 due to errors in revenue and cost recognition, impacting net profit and other financial metrics [15][17]. - Specific adjustments included a reduction in revenue of CNY 2.40 million and a reduction in net profit of CNY 6.14 million due to unrecognized income from certain projects [15][17]. - The company has also recognized impairment losses on inventory amounting to CNY 24.93 million, reflecting a more cautious approach to inventory valuation [18].